Corvus Pharmaceuticals (CRVS) Receivables - Net (2022 - 2025)
Corvus Pharmaceuticals (CRVS) has 4 years of Receivables - Net data on record, last reported at $32000.0 in Q3 2025.
- For Q3 2025, Receivables - Net fell 54.29% year-over-year to $32000.0; the TTM value through Sep 2025 reached $32000.0, down 54.29%, while the annual FY2024 figure was $75000.0, 188.46% up from the prior year.
- Receivables - Net reached $32000.0 in Q3 2025 per CRVS's latest filing, down from $86000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $588000.0 in Q4 2022 and bottomed at $11000.0 in Q3 2023.
- Average Receivables - Net over 4 years is $102800.0, with a median of $52500.0 recorded in 2024.
- Peak YoY movement for Receivables - Net: plummeted 95.58% in 2023, then soared 536.36% in 2024.
- A 4-year view of Receivables - Net shows it stood at $588000.0 in 2022, then tumbled by 95.58% to $26000.0 in 2023, then soared by 188.46% to $75000.0 in 2024, then plummeted by 57.33% to $32000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $32000.0 in Q3 2025, $86000.0 in Q2 2025, and $79000.0 in Q1 2025.